News
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
The primary outcome was the proportion of children who developed any adverse events while receiving first-line tuberculosis treatment across all doses, and secondary outcomes included drug-related ...
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. How you manage a ...
The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...
Healthbeat on MSN3d
Tuberculosis is on the rise in NYC. Here’s why — and what to know about the disease.In recent years, cases of tuberculosis have started to tick up in New York City. Here’s what to know about the infectious ...
Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...
I thought you could help with a stubborn problem. I am a healthy and active 78-year-old woman who, I admit, likes to look ...
Key points A 5-year-old boy from rural east-central Ontario was referred to the urgent dermatology service with tender ...
Sen. Dick Durbin’s (D-Ill.) decision not to seek a sixth term in the Senate is expected to tee up a spirited Democratic primary to replace him next year. Durbin, the No. 2 Senate Democrat who ...
Tuberculosis (TB), a potentially fatal disease ... A small number of people who become infected develop what is called 'primary disease', usually within eight weeks of exposure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results